𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas

✍ Scribed by Jörg Felsberg; Niklas Thon; Sabina Eigenbrod; Bettina Hentschel; Michael C. Sabel; Manfred Westphal; Gabriele Schackert; Friedrich Wilhelm Kreth; Torsten Pietsch; Markus Löffler; Michael Weller; Guido Reifenberger; Jörg C. Tonn; for the German Glioma Network

Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
534 KB
Volume
129
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Epigenetic silencing of the O^6^‐methylguanine‐DNA methyltransferase (MGMT) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ). We investigated whether glioblastoma recurrence is associated with changes in the promoter methylation status and the expression of MGMT and the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2 in pairs of primary and recurrent glioblastomas of 80 patients, including 64 patients treated with radiotherapy and TMZ after the first operation. Among the primary tumors, the MGMT promoter was methylated in 31 patients and unmethylated in 49 patients. In 71 patients (89%), the MGMT promoter methylation status of the primary tumor was retained at recurrence. MGMT promoter methylation, but not MGMT protein expression, was associated with longer progression‐free survival, overall survival and postrecurrence survival (PRS). Moreover, PRS was increased under salvage chemotherapy. Investigation of primary and recurrent glioblastomas of 43 patients did not identify promoter methylation in any of the four MMR genes. However, recurrent glioblastomas demonstrated significantly lower MSH2, MSH6 and PMS2 protein expression as detected by immunohistochemistry. In conclusion, reduced expression of MMR proteins, but not changes in MGMT promoter methylation, is characteristic of glioblastomas recurring after the current standards of care.

📜 SIMILAR VOLUMES

Genetic investigation of DNA-repair path
Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer
✍ Clemens Schafmayer; Stephan Buch; Jan Hendrik Egberts; Andre Franke; Mario Brosc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 182 KB 👁 1 views

## Abstract Mutations in DNA repair genes have previously been identified as causative factors for hereditary nonpolyposis colon cancer (HNPCC). Recent evidence also supports an association between DNA sequence variation in these genes and sporadic colorectal carcinoma (CRC). Genetic investigation

Molecular characterization of the spectr
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)
✍ Heleen van der Klift; Juul Wijnen; Anja Wagner; Paul Verkuilen; Carli Tops; Roby 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 577 KB

## Abstract A systematic search by Southern blot analysis in a cohort of 439 hereditary nonpolyposis colorectal cancer (HNPCC) families for genomic rearrangements in the main mismatch repair (MMR) genes, namely, __MSH2__, __MLH1__, __MSH6__, and __PMS2__, identified 48 genomic rearrangements causat

Mutation analysis of the MLH1, MSH2 and
Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: A population-based study in northern Sweden
✍ Kristina Cederquist; Monica Emanuelsson; Ingela Göransson; Elke Holinski-Feder; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Abstract Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that predisposes to predominantly colorectal and endometrial cancers due to germline mutations in DNA mismatch repair genes, mainly __MLH1__, __MSH2__ and in families with excess endometrial cancer also

Erratum to Cederquist et al., “Mutation
Erratum to Cederquist et al., “Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium—A population-based study in northern Sweden.” Int J Cancer 2004; 109(3):370–376
📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2004) 109(3) 370–376DOI: 10.1002/ijc.11718